The central research goal of the Ito Lab is the expansion of our understanding of the regulatory pathways controlling the equilibrium of healthy and malignant hematopoietic stem cells. After his postdoctoral training, first at Keio University, and then Harvard Medical School, he joined the Albert Einstein College of Medicine (Einstein) faculty in 2012. Dr. Ito is currently an Associate Professor of Cell Biology and Medicine, and the Director of Scientific Resources of the Stem Cell Institute at Einstein. He has a relevant background in stem cell biology, hematology and oncology, and sickle cell disease pathogenesis, and at the core of his work is the process of stem cell division, and the resulting balance between self-renewal or differentiation, which directly impacts tissue homeostasis. Dr. Ito's lab is also devoting increased attention to targeting cellular metabolism as a therapeutic strategy, and have cut a path along the leading edge of research in the pathogenesis of myelodysplastic syndrome to facilitate a major contribution to the improvement of transplantation efficiency and the development of new therapies and treatments, and potentially even cures, for many forms of hematologic pathology.